Your browser doesn't support javascript.
loading
The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis.
Staropoli, Nicoletta; Ciliberto, Domenico; Del Giudice, Teresa; Iuliano, Eleonora; Cucè, Maria; Grillone, Francesco; Salvino, Angela; Barbieri, Vito; Russo, Antonio; Tassone, Pierfrancesco; Tagliaferri, Pierosandro.
Afiliação
  • Staropoli N; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Ciliberto D; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Del Giudice T; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Iuliano E; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Cucè M; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Grillone F; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Salvino A; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Barbieri V; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 90127 Palermo, Italy.
  • Tassone P; Translational Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.
  • Tagliaferri P; Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy. Electronic address: tagliaferri@unicz.it.
Crit Rev Oncol Hematol ; 131: 83-89, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30293710
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidores de Poli(ADP-Ribose) Polimerases / Poli(ADP-Ribose) Polimerase-1 Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidores de Poli(ADP-Ribose) Polimerases / Poli(ADP-Ribose) Polimerase-1 Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans Idioma: En Revista: Crit Rev Oncol Hematol Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália